EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IGA NEPHROPATHY (IGAN): INTERIM ANALYSIS (IA) OF THE PHASE 3 APPLAUSE-IGAN STUDY

被引：0
|
作者：
Rizk, Dana V. [1 ]
Kollins, Dmitrij [2 ]
Papachristofi, Olympia [2 ]
Hach, Thomas [2 ]
Jacinto-Sanders, Severina [2 ]
Merkel, Tobias [2 ]
Renfurm, Ronny [2 ]
Perkovic, Vlado [3 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Novartis Pharma AG, Basel, Switzerland
[3] Univ New South Wales, Kensington, NSW, Australia
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2024年 / 83卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
3
引用
收藏
页码：699 / 700
页数：2
相关论文
共 50 条
  • [31] An open-label study evaluating the safety and efficacy of budesonide in patients with IgA nephropathy at high risk of progression
    Bogdan Obrișcă
    Alexandra Vornicu
    Valentin Mocanu
    George Dimofte
    Andreea Andronesi
    Raluca Bobeică
    Roxana Jurubiță
    Bogdan Sorohan
    Nicu Caceaune
    Gener Ismail
    [J]. Scientific Reports, 13
  • [32] Interim analysis of a study evaluating the safety and efficacy of rivastigmine in patients not responding adequately to donepezil
    Figiel, G
    Ibrahim, G
    Moriarty, P
    Koumaras, B
    Chen, M
    Mirski, D
    [J]. GERONTOLOGIST, 2004, 44 : 259 - 259
  • [33] Phase 2b ORIGIN study open label extension with atacicept in patients with IgA nephropathy and persistent proteinuria: week 72 interim analysis
    Lafayette, Richard
    Maes, Bart
    Israni, Rubeen
    Lin, Celia
    Wei, Xuelian
    Barbour, Sean
    Phoon, Richard
    Kim, Sung Gyun
    Tesar, Vladimir
    Floege, Juergen
    Jha, Vivekanand
    Barratt, Jonathan
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I53 - I55
  • [34] An Interim Analysis of a Phase 3, Open-Label Study Indicates Efficacy and Safety of RBX2660 in Patients With Recurrent Clostridioides difficile Infection
    Khanna, Sahil
    Dubberke, Erik R.
    Knapple, Whitfield L.
    Feuerstadt, Paul
    Assi, Maha
    Ng, Samson
    Guthmueller, Beth
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S96 - S96
  • [35] Safety and efficacy of intravenous onasemnogene abeparvovec in patients with spinal muscular atrophy: interim findings from the phase 3 SMART study
    McMillan, H.
    Baranello, G.
    Farrar, M.
    Zaidman, C.
    Seibert, J.
    Bernardo, R.
    Alecu, I.
    Freischlager, F.
    Muntoni, F.
    [J]. NEUROMUSCULAR DISORDERS, 2023, 33 : S191 - S191
  • [36] 12M Interim Analysis of an Open-Label, Non-Randomized Extension of a Phase 2 Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Iptacopan in Subjects With C3G
    Nester, Carla M.
    Eisenberger, Ute
    Karras, Alexandre
    Lightstone, Liz
    Praga, Manuel
    Remuzzi, Giuseppe
    Jose Soler, Maria
    Liu, Junhao
    Meier, Matthias
    Tawfik, Ronda
    Junge, Guido
    Biondani, Andrea
    Trapani, Angelo J.
    Webb, Nicholas
    Wong, Edwin K.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 190 - 190
  • [37] Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study
    Ventura, Paolo
    Bonkovsky, Herbert L.
    Gouya, Laurent
    Aguilera-Peiro, Paula
    Bissell, D. Montgomery
    Stein, Penelope E.
    Balwani, Manisha
    Anderson, D. Karl E.
    Parker, Charles
    Kuter, David J.
    Monroy, Susana
    Oh, Jeeyoung
    Ritchie, Bruce
    Ko, John J.
    Hua, Zhaowei
    Sweetser, Marianne T.
    Sardh, Eliane
    [J]. LIVER INTERNATIONAL, 2022, 42 (01) : 161 - 172
  • [38] INTERIM RESULTS OF PHASE 1 AND 2 TRIALS TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND CLINICAL ACTIVITY OF BION-1301 IN PATIENTS WITH IGA NEPHROPATHY
    Barratt, Jonathan
    Hour, Billy
    Sibley, Cailin
    Mittan, Angelique
    Roy, Suzanne
    Stromatt, Colleen
    Endsley, Aaron
    Lo, Jeannette
    Glicklich, Alan
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [39] Efficacy and safety of Cinryze for the prevention of hereditary angioedema attacks in children: interim results of a Phase 3 study
    Aygoren-Pursun, E.
    Moldovan, D.
    Christensen, J.
    van, Leerberghe A.
    Wu, Y.
    Schranz, J.
    Martinez-Saguer, I
    Soteres, D.
    [J]. ALLERGY, 2016, 71 : 296 - 296
  • [40] Update to the long-term safety and efficacy of iptacopan in C3G: 33-month extension study data from patients enrolled in a phase 2 study
    Nester, Carla M.
    Eisenberger, Ute
    Karras, Alexandre
    Le Quintrec, Moglie
    Lightstone, Liz
    Praga, Manuel
    Remuzzi, Giuseppe
    Soler Romeo, Maria Jose
    Liu, Junhao
    Meier, Matthias
    Webb, Nicholas
    Wong, Edwin
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I254 - I254
12345